Channel sialic acids limit hERG channel activity during the ventricular action potential

FASEB Journal

Volumn 27, Issue 2, 2013, Pages 622-631

  Norring, Sarah A ^a   Ednie, Andrew R ^a   Schwetz, Tara A ^a   Du, Dongping ^b   Yang, Hui ^b   Bennett, Eric S ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b University of South Florida   (United States)

Author keywords

Arrhythmias; Cardiac; Ion channel; N glycosylation; Sialylation; Voltage gated potassium channel

Indexed keywords

POTASSIUM CHANNEL HERG; SIALIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; BIOTINYLATION; CHANNEL GATING; CONTROLLED STUDY; DEGLYCOSYLATION; ENZYME INACTIVATION; FEMALE; GLYCOSYLATION; HEART MUSCLE POTENTIAL; HEART REPOLARIZATION; HEART VENTRICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIALYLATION; STEADY STATE;

ACTION POTENTIALS; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ETHER-A-GO-GO POTASSIUM CHANNELS; GLYCOSYLATION; HEART VENTRICLES; HUMANS; ION CHANNEL GATING; MODELS, CARDIOVASCULAR; PATCH-CLAMP TECHNIQUES; RECOMBINANT PROTEINS; SIALIC ACIDS;

EID: 84873431362     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-214387     Document Type: Article

References (60)

1. Sanguinetti, M. C., Jiang, C., Curran, M. E., and Keating, M. T. (1995) A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell 81, 299-307
2. Trudeau, M. C., Warmke, J. W., Ganetzky, B., and Robertson, G. A. (1995) HERG, a human inward rectifier in the voltagegated potassium channel family. Science 269, 92-95
3. Warmke, J. W., and Ganetzky, B. (1994) A family of potassium channel genes related to eag in Drosophila and mammals. Proc. Natl. Acad. Sci. U. S. A. 91, 3438-3442
4. Pond, A. L., and Nerbonne, J. M. (2001) ERG proteins and functional cardiac I(Kr) channels in rat, mouse, and human heart. Trends Cardiovasc. Med. 11, 286-294
5. Jones, E. M., Roti Roti, E. C., Wang, J., Delfosse, S. A., and Robertson, G. A. (2004) Cardiac IKr channels minimally comprise hERG 1a and 1b subunits. J. Biol. Chem. 279, 44690-44694
6. Bertaso, F., Sharpe, C. C., Hendry, B. M., and James, A. F. (2002) Expression of voltage-gated K? channel s in human atrium. Basic Res. Cardiol. 97, 424-433
7. Hong, K., Bjerregaard, P., Gussak, I., and Brugada, R. (2005) Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J. Cardiovasc. Electrophysiol. 16, 394-396
8. Keating, M. T., and Sanguinetti, M. C. (2001) Molecular and cellular mechanisms of cardiac arrhythmias. Cell 104, 569-580
9. Sanguinetti, M. C., Curran, M. E., Spector, P. S., and Keating, M. T. (1996) Spectrum of HERG K?-channel dysfunction in an inherited cardiac arrhythmia. Proc. Natl. Acad. Sci. U. S. A. 93, 2208-2212
10. Sanguinetti, M. C., and Tristani-Firouzi, M. (2006) hERG potassium channels and cardiac arrhythmia. Nature 440, 463-469
11. Roden, D. M., and Balser, J. R. (1999) A plethora of mechanisms in the HERG-related long QT syndrome. Genetics meets electrophysiology. Cardiovasc. Res. 44, 242-246
12. Cordeiro, J. M., Brugada, R., Wu, Y. S., Hong, K., and Dumaine, R. (2005) Modulation of I(Kr) inactivation by mutation N588K in KCNH2: A link to arrhythmogenesis in short QT syndrome. Cardiovasc. Res. 67, 498-509
13. Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., and Keating, M. T. (1995) A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80, 795-803
14. Spector, P. S., Curran, M. E., Zou, A., Keating, M. T., and Sanguinetti, M. C. (1996) Fast inactivation causes rectification of the IKr channel. J. Gen. Physiol. 107, 611-619
15. Bennett, E., Urcan, M. S., Tinkle, S. S., Koszowski, A. G., and Levinson, S. R. (1997) Contribution of sialic acid to the voltage dependence of sodium channel gating. A possible electrostatic mechanism. J. Gen. Physiol. 109, 327-343
16. Bennett, E. S. (2002) Isoform-specific effects of sialic acid on voltage-dependent Na-channel gating: Functional sialic acids are localized to the S5-S6 loop of domain I. J. Physiol. 538, 675-690
17. Ednie, A. R., and Bennett, E. S. (2011) Modulation of voltagegated ion channels by sialylation. Compr. Physiol. 2, 1269-1301, 2012.
18. Johnson, D., and Bennett, E. S. (2006) Isoform-specific effects of the beta2 subunit on voltage-gated sodium channel gating. J. Biol. Chem. 281, 25875-25881
19. Johnson, D., and Bennett, E. S. (2008) Gating of the shaker potassium channel is modulated differentially by N-glycosylation and sialic acids. Pflügers Arch. 456, 393-405
20. Johnson, D., Montpetit, M. L., Stocker, P. J., and Bennett, E. S. (2004) The sialic acid component of the beta1 subunit modulates voltage-gated sodium channel function. J. Biol. Chem. 279, 44303-44310
21. Montpetit, M. L., Stocker, P. J., Schwetz, T. A., Harper, J. M., Norring, S. A., Schaffer, L., North, S. J., Jang-Lee, J., Gilmartin, T., Head, S. R., Haslam, S. M., Dell, A., Marth, J. D., and Bennett, E. S. (2009) Regulated and aberrant glycosylation modulate cardiac electrical signaling. Proc. Natl. Acad. Sci. U. S. A. 106, 16517-16522
22. Schwetz, T. A., Norring, S. A., and Bennett, E. S. (2010) N-glycans modulate K(v)1.5 gating but have no effect on K(v)1.4 gating. Biochim. Biophys. Acta 1798, 367-375
23. Schwetz, T. A., Norring, S. A., Ednie, A. R., and Bennett, E. S. (2011) Sialic acids attached to O-glycans modulate voltage-gated potassium channel gating. J. Biol. Chem. 286, 4123-4132
24. Stocker, P. J., and Bennett, E. S. (2006) Differential sialylation modulates voltage-gated Na-channel gating throughout the developing myocardium. J. Gen. Physiol. 127, 253-265
25. Thornhill, W. B., Wu, M. B., Jiang, X., Wu, X., Morgan, P. T., and Margiotta, J. F. (1996) Expression of Kv1.1 delayed rectifier potassium channels in Lec mutant Chinese hamster ovary cell lines reveals a role for sialidation in channel function. J. Biol. Chem. 271, 19093-19098
26. Watanabe, I., Wang, H. G., Sutachan, J. J., Zhu, J., Recio-Pinto, E., and Thornhill, W. B. (2003) Glycosylation affects rat Kv1.1 potassium channel gating by a combined surface potential and cooperative subunit interaction mechanism. J. Physiol. 550, 51-66
27. Watanabe, I., Zhu, J., Sutachan, J. J., Gottschalk, A., Recio-Pinto, E., and Thornhill, W. B. (2007) The glycosylation state of Kv1.2 potassium channels affects trafficking, gating, and simulated action potentials. Brain Res. 1144, 1-18
28. Ufret-Vincenty, C. A., Baro, D. J., Lederer, W. J., Rockman, H. A., Quinones, L. E., and Santana, L. F. (2001) Role of sodium channel deglycosylation in the genesis of cardiac arrhythmias in heart failure. J. Biol. Chem. 276, 28197-28203
29. Ufret-Vincenty, C. A., Baro, D. J., and Santana, L. F. (2001) Differential contribution of sialic acid to the function of repolarizing K-currents in ventricular myocytes. Am. J. Physiol. Cell Physiol. 281, C464-C474
30. Al-Owain, M., Mohamed, S., Kaya, N., Zagal, A., Matthijs, G., and Jaeken, J. (2010) A novel mutation and first report of dilated cardiomyopathy in ALG6-CDG (CDG-Ic): A case report. Orphanet J. Rare Dis. 5, 7
31. Footitt, E. J., Karimova, A., Burch, M., Yayeh, T., Dupre, T., Vuillaumier-Barrot, S., Chantret, I., Moore, S. E., Seta, N., and Grunewald, S. (2009) Cardiomyopathy in the congenital disorders of glycosylation (CDG): A case of late presentation and literature review. Short report 186. [Online]. J. Inherit. Metab Dis. doi: 10.1007/s10545-009-1262-1
32. Freeze, H. H. (2006) Genetic defects in the human glycome. Nat. Rev. Genet. 7, 537-551
33. Gehrmann, J., Sohlbach, K., Linnebank, M., Bohles, H. J., Buderus, S., Kehl, H. G., Vogt, J., Harms, E., and Marquardt, T. (2003) Cardiomyopathy in congenital disorders of glycosylation. Cardiol. Young 13, 345-351
34. Jaeken, J. (2003) Komrower lecture. Congenital disorders of glycosylation (CDG): It's all in it! J. Inherit. Metab. Dis. 26, 99-118
35. Jaeken, J. (2004) Congenital disorders of glycosylation (CDG): Update and new developments. J. Inherit. Metab. Dis. 27, 423-426
36. Jaeken, J., and Carchon, H. (2004) Congenital disorders of glycosylation: A booming chapter of pediatrics. Curr. Opin. Pediatr. 16, 434-439
37. Kranz, C., Basinger, A. A., Gucsavas-Calikoglu, M., Sun, L., Powell, C. M., Henderson, F. W., Aylsworth, A. S., and Freeze, H. H. (2007) Expanding spectrum of congenital disorder of glycosylation Ig (CDG-Ig): Sibs with a unique skeletal dysplasia, hypogammaglobulinemia, cardiomyopathy, genital malformations, and early lethality. Am. J. Med. Genet. A 143A, 1371-1378
38. Gong, Q., Anderson, C. L., January, C. T., and Zhou, Z. (2002) Role of glycosylation in cell surface expression and stability of HERG potassium channels. Am. J. Physiol. Heart Circ. Physiol. 283, H77-H84
39. Stanley, P., Caillibot, V., and Siminovitch, L. (1975) Selection and characterization of eight phenotypically distinct lines of lectin-resistant Chinese hamster ovary cell. Cell 6, 121-128
40. Leroy, J. G. (2006) Congenital disorders of N-glycosylation including diseases associated with O-as well as N-glycosylation defects. Pediatr. Res. 60, 643-656
41. Marquardt, T., and Denecke, J. (2003) Congenital disorders of glycosylation: Review of their molecular bases, clinical presentations and specific therapies. Eur. J. Pediatr. 162, 359-379
42. Ohtsubo, K., and Marth, J. D. (2006) Glycosylation in cellular mechanisms of health and disease. Cell 126, 855-867
43. Ten Tusscher, K. H., Noble, D., Noble, P. J., and Panfilov, A. V. (2004) A model for human ventricular tissue. Am. J. Physiol. Heart Circ. Physiol. 286, H1573-H1589
44. Ten Tusscher, K. H., and Panfilov, A. V. (2006) Alternans and spiral breakup in a human ventricular tissue model. Am. J. Physiol. Heart Circ. Physiol. 291, H1088-H1100
45. Liengme, B. V. (2002) A Guide to Microsoft Excel 2002 for Scientists and Engineers, 3rd Ed., Elsevier, New York
46. Du, D., Yang, H., Norring, S. A., and Bennett, E. S. (2011) Multi-scale modeling of glycosylation modulation dynamics in cardiac electrical signaling. IEEE Proc. Eng. Med. Biol. Soc. 2011, 104-107
47. Petrecca, K., Atanasiu, R., Akhavan, A., and Shrier, A. (1999) N-linked glycosylation sites determine HERG channel surface membrane expression. J. Physiol. 515, 41-48
48. Zhu, J., Recio-Pinto, E., Hartwig, T., Sellers, W., Yan, J., and Thornhill, W. B. (2009) The Kv1.2 potassium channel: The position of an N-glycan on the extracellular linkers affects its protein expression and function. Brain Res. 1251, 16-29
49. Krasemann, T., Bente, K., and Burkhardtsmaier, G. (2010) The corrected QT interval in 24 h ECGs in neonates. Clin. Res. Cardiol. 99, 309-314
50. Taubel, J., Naseem, A., Harada, T., Wang, D., Arezina, R., Lorch, U., and Camm, A. J. (2010) Levofloxacin can be used effectively as a positive control in thorough QT/QTc studies in healthy volunteers. Br. J. Clin. Pharmacol. 69, 391-400
51. Gintant, G. (2011) An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation. Pharmacol. Ther. 129, 109-119
52. Vargas, H. M., Bass, A. S., Breidenbach, A., Feldman, H. S., Gintant, G. A., Harmer, A. R., Heath, B., Hoffmann, P., Lagrutta, A., Leishman, D., McMahon, N., Mittelstadt, S., Polonchuk, L., Pugsley, M. K., Salata, J. J., and Valentin, J. P. (2008) Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics. J. Pharmacol. Toxicol. Methods 58, 72-76
53. Priest, B. T., Bell, I. M., and Garcia, M. L. (2008) Role of hERG potassium channel assays in drug development. Channels (Austin) 2, 87-93
54. Wang, H. Z., Shi, H., Liao, S. J., and Wang, Z. (1999) Inactivation gating determines nicotine blockade of human HERG channels. Am. J. Physiol. 277, H1081-H1088
55. Jo, S. H., Hong, H. K., Chong, S. H., Lee, H. S., and Choe, H. (2009) H(1) antihistamine drug promethazine directly blocks hERG K? channel . Pharmacol. Res. 60, 429-437
56. Drici, M. D., and Barhanin, J. (2000) Cardiac K? channel s and drug-acquired long QT syndrome. Therapie 55, 185-193
57. Witchel, H. J. (2011) Drug-induced hERG block and long QT syndrome. Cardiovasc. Ther. 29, 251-259
58. Park, K. H., Kwok, S. M., Sharon, C., Berga, R., and Sesti, F. (2003) N-Glycosylation-dependent block is a novel mechanism for drug-induced cardiac arrhythmia. FASEB J. 17, 2308-2309
59. Hayashi, K., Fujino, N., Ino, H., Uchiyama, K., Sakata, K., Konno, T., Masuta, E., Funada, A., Sakamoto, Y., Tsubokawa, T., Hodatsu, A., Yasuda, T., Kanaya, H., Kim, M. Y., Kupershmidt, S., Higashida, H., and Yamagishi, M. (2011) A KCR1 variant implicated in susceptibility to the long QT syndrome. J. Mol. Cell. Cardiol. 50, 50-57
60. Nakajima, T., Hayashi, K., Viswanathan, P. C., Kim, M. Y., Anghelescu, M., Barksdale, K. A., Shuai, W., Balser, J. R., and Kupershmidt, S. (2007) HERG is protected from pharmacological block by alpha-1,2-glucosyltransferase function. J. Biol. Chem. 282, 5506-5513